Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jane S Paulsen, PhD
University of Wisconsin, Madison
Principal Investigator - Michael D Geschwind, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California
Los Angeles, California, United States
Recruiting - University of California
San Francisco, California, United States
Recruiting - University of Colorado
Denver, Colorado, United States
Recruiting - Georgia State University Research Foundation
Atlanta, Georgia, United States
Recruiting - Loyola University
Chicago, Illinois, United States
Recruiting - Columbia University
New York, New York, United States
Recruiting - Oregon Health & Science University
Portland, Oregon, United States
Recruiting - Brown University
Providence, Rhode Island, United States
Recruiting - University of Texas Health Science Center
Houston, Texas, United States
Not, yet, recruiting - University of Texas
San Antonio, Texas, United States
Not, yet, recruiting - University of Utah
Salt Lake City, Utah, United States
Recruiting - University of Washington
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2022
- Primary completion
- 30 Jun 2027
- Completion
- 31 Aug 2027
- Last update posted
- 15 Jan 2026
- Registered enrollment
- 660
- Registry id
- NCT05677880
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.